M&T Bank Corp Raises Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

M&T Bank Corp grew its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 8.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 34,822 shares of the medical instruments supplier’s stock after purchasing an additional 2,654 shares during the period. M&T Bank Corp’s holdings in DENTSPLY SIRONA were worth $1,239,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. 9258 Wealth Management LLC acquired a new position in DENTSPLY SIRONA during the fourth quarter valued at $203,000. Russell Investments Group Ltd. boosted its stake in shares of DENTSPLY SIRONA by 5.3% in the fourth quarter. Russell Investments Group Ltd. now owns 900,306 shares of the medical instruments supplier’s stock worth $32,042,000 after buying an additional 45,711 shares during the last quarter. Headlands Technologies LLC acquired a new stake in DENTSPLY SIRONA during the fourth quarter worth about $30,000. Sonen Capital LLC acquired a new position in DENTSPLY SIRONA in the fourth quarter valued at approximately $259,000. Finally, GAMMA Investing LLC purchased a new stake in DENTSPLY SIRONA in the 4th quarter worth approximately $55,000. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Down 1.1 %

Shares of XRAY opened at $27.89 on Friday. The stock has a 50 day moving average price of $31.60 and a 200 day moving average price of $32.57. DENTSPLY SIRONA Inc. has a one year low of $26.27 and a one year high of $41.65. The company has a current ratio of 1.43, a quick ratio of 0.97 and a debt-to-equity ratio of 0.54.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last issued its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, meeting analysts’ consensus estimates of $0.42. The business had revenue of $953.00 million during the quarter, compared to analysts’ expectations of $969.45 million. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The company’s quarterly revenue was down 2.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.39 earnings per share. As a group, analysts forecast that DENTSPLY SIRONA Inc. will post 2.03 EPS for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 2.29%. The ex-dividend date of this dividend was Wednesday, March 27th. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. DENTSPLY SIRONA’s payout ratio is currently -145.45%.

Analysts Set New Price Targets

Several research firms have recently weighed in on XRAY. The Goldman Sachs Group cut their target price on shares of DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating for the company in a report on Monday, May 6th. StockNews.com cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Friday, May 3rd. SVB Leerink initiated coverage on DENTSPLY SIRONA in a report on Monday, February 26th. They issued an “outperform” rating and a $42.00 price target for the company. Needham & Company LLC cut their price objective on DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating for the company in a research report on Friday, May 3rd. Finally, Evercore ISI reduced their target price on DENTSPLY SIRONA from $40.00 to $35.00 and set an “outperform” rating for the company in a research note on Friday, May 3rd. Five investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $35.22.

Read Our Latest Analysis on XRAY


(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Further Reading

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.